Category: Myelodysplastic Syndromes

Optimizing HSCT in Blood Cancers

Lori Muffly MD, MS, Stanford Medicine, Stanford, CA

MDS: Patient-Centered Approaches to Diagnosis and Treatment

Mikkael A. Sekeres, MD, MS, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL

Unpacking Mantle Cell Lymphoma

Krish Patel, MD, Swedish Cancer Institute, Seattle, WA

Clinical Perspectives on Hereditary Myeloid and Hematologic Disorders

Ximena Jordan-Bruno, MD, University of Pennsylvania, Philadelphia, PA

Highlights from attending the 2023 ASH Annual Meeting

Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY

Myelodysplastic Syndromes (MDS): Caring for Low and High-Risk Patients

James M. Foran, MD, FRCPC, Mayo Clinic Cancer Center, Jacksonville, FL
Scroll to Top